RNA (7)

Welcome to the mRNA- Based Therapeutics Summit Europe: Expanding the Therapeutic Applicability of mRNA- Based Drugs

Built with biopharmaceutical industry insights, this in-person conference will bring together key opinion leaders from Europe and the rest of the world to delve deep into the challenges associated with successfully designing and developing the next-generation of mRNA-based vaccines & therapeutics with improved specificity, delivery & efficacy for immuno-oncology, infectious diseases and beyond.

With 20+ pioneering large pharma, biotech and academic experts who are shaping the landscape of mRNA- based therapeutics for the scientific community world-wide, hear how they address the major challenges facing the industry.


Optimise the Efficacy, Cell- & Tissue- Specificity & Translatability of Your mRNA- Based Pipeline

With the limitless opportunity of mRNA- based Therapeutics across different modalities, consider the challenges of efficacy and improve cell- & tissue- specificity with expert insights from Professor Drew Weissman, Strand Therapeutics & Chalmers University of Technology


Explore Applications of mRNA- Based Therapeutics Beyond Infectious Diseases

From immune-oncology to rare and autoimmune diseases, dive into emerging applications and potential challenges of mRNA- based vaccines and therapeutics beyond infectious diseases with case studies from Moderna, BioNTech & Ethris


Navigate New & Emerging Delivery Technologies for mRNA- Based Therapeutics

Take yourself to the forefront of mRNA delivery system development, from structure through to administration with insights from BioNTech, Johnson & Johnson & 20Med Therapeutics


Strategise Your Scalable & Global mRNA-Based Vaccine Development 

With the global outreach of mRNA- based vaccines, scalability is a major hurdle. Hear the latest technological advances and regulatory standards in mRNA- based vaccine and therapeutic landscape from Sanofi, Ziphius Vaccines & Arcturus Therapeutics


Tune into How Companies are Differentiating Their Pipelines Beyond mRNA- Based Vaccines

With the success of mRNA- based vaccines fulfilling novel technologies and therapies such as mRNA- based protein replacement, hear from companies like Strand Therapeutics, Turn Biotechnologies & Orna Therapeutics on the emerging strategies that will enable innovation in the field

Expert Speakers Include:

Health & Safety

Your health, safety and well-being remains our highest priority, As you may be aware the German government is now applying the 2G rule. The 2G rule means that to attend the conference you will have to provide proof that you are fully vaccinated.

Therefore, in order to attend this conference, you will be required to show proof of vaccination.

Additionally, you will be required to complete our mandatory Health Declaration before arriving onsite. As part of this declaration, you will be asked to confirm you acknowledge and accept the mandate to provide proof of vaccination, or a negative test as detailed above. Failure to provide this documentation will result in you being denied access to the event. 

For further information around Health and Safety onsite, please visit our FAQ here.

*Please note, this is subject to change at any time without prior notice.

Snapshot of Companies Attending

companies attending (2)

Group Discounts Available

Group Discounts - Jess (1)

Maximize value for money using special team discounts:

10% discount - 3 delegates
15% discount - 4 delegates
20% discount - 5+ delegates

Proud to Partner With:

Sartorius-Logo_BIA-separations-Logo_Part-of Sartorius
Screenshot 2021-11-22 113041
Ardena_General_logo+hoog-03 (002)
47061_logo_Codex_landscape_color_CMYK (002)
ArrantaBio_Logo_RGB (002)
cytiva_logo_stk_color_pos_rgb (003)
Intertek_Logo_BLK_Strap_BLK_YELL_Dot_RGB_HR (1)

Other Events In The Undruggable Series